In the SELECT trial, which ran from October 2018 through June 2023, researchers enrolled patients 45 years of age or older who had pre-existing cardiovascular disease and a body mass index of 27 or greater but no history of diabetes
You should seek medical attention if you notice: Persistent or heavy bleeding Dark or black stools (which may indicate internal bleeding) Severe abdominal pain Dizziness or weakness The Centers for Disease Control and Prevention advises that a healthcare professional should check any unexplained blood in stool
This test catches early deficiency before symptoms develop
Increased anxiety could be related to Wegovys side effects, changes in eating patterns, blood sugar fluctuations, or other factors
These shifts create weight changes unrelated to fat loss but visible on the scale
In our study, we examine: Trends in GLP-1 prevalence, adherence data, and potential obstacles to continued use Impacts on mortality among individuals taking these drugs Implications for assessing metabolic risk and the crucial role electronic health records (EHRs) will play Key results GLP-1s may drive 0.2%0.5% annual mortality improvement, realized over a 20-year period
